Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Antiplatelet agents for the secondary prevention of ischaemic stroke in patients with or without renal dysfunction
I. K. Wang
, T. H. Yen
, Y. C. Guo
, Y. Sun
,
L. M. Lien
, W. L. Chang
, P. L. Chen
, Y. C. Yang
, F. C. Sung
, C. Y. Hsu
Department of Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antiplatelet agents for the secondary prevention of ischaemic stroke in patients with or without renal dysfunction'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acetylsalicylic Acid
100%
Brain Ischemia
100%
Secondary Prevention
100%
Antiplatelet Drug
100%
Clopidogrel
100%
Apoplexy
83%
Glomerular Filtration Rate
50%
Antiplatelet
50%
Hazard Ratio
33%
Group Therapy
33%
Mortality Rate
16%
Nursing and Health Professions
Brain Ischemia
100%
Secondary Prevention
100%
Antithrombocytic Agent
100%
Clopidogrel
100%
Confidence Interval
66%
Estimated Glomerular Filtration Rate
50%
Dual Antiplatelet Therapy
50%
Hazard Ratio
33%
Mortality Rate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
100%
Acetylsalicylic Acid
100%
Antithrombocytic Agent
100%
Clopidogrel
100%
Antiplatelet
50%
Mortality Rate
16%